| Q-o-Q | REVENUES | OPERATING PROFIT | PROFIT AFTER TAX | EPS | Updated : 20-Sep-21 | Details👇 |
| Consolidated | Jun2021 Audited |
Mar2021 UnAudited |
Dec2020 UnAudited |
Sep2020 UnAudited |
Jun2020 Audited |
Mar2020 UnAudited |
Dec2019 UnAudited |
Sep2019 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹2,134 Cr | ₹1,937 Cr | ₹1,995 Cr | ₹2,017 Cr | ₹2,056 Cr | ₹1,946 Cr | ₹1,966 Cr | ₹2,005 Cr |
| Expenses | ₹1,457 Cr | ₹1,355 Cr | ₹1,388 Cr | ₹1,382 Cr | ₹1,395 Cr | ₹1,398 Cr | ₹1,426 Cr | ₹1,464 Cr |
| Operating Income | ₹677 Cr | ₹582 Cr | ₹607 Cr | ₹635 Cr | ₹661 Cr | ₹548 Cr | ₹540 Cr | ₹541 Cr |
| Other Income | ₹40 Cr | ₹39 Cr | ₹8 Cr | ₹6 Cr | ₹4 Cr | ₹15 Cr | ₹53 Cr | ₹34 Cr |
| Interest | ₹68 Cr | ₹73 Cr | ₹91 Cr | ₹92 Cr | ₹102 Cr | ₹102 Cr | ₹111 Cr | ₹116 Cr |
| Depreciation | ₹165 Cr | ₹165 Cr | ₹167 Cr | ₹165 Cr | ₹161 Cr | ₹168 Cr | ₹163 Cr | ₹163 Cr |
| Profit Before Tax | ₹484 Cr | ₹383 Cr | ₹357 Cr | ₹384 Cr | ₹402 Cr | ₹293 Cr | ₹319 Cr | ₹296 Cr |
| Profit After Tax | ₹330 Cr | ₹324 Cr | ₹297 Cr | ₹310 Cr | ₹321 Cr | ₹314 Cr | ₹251 Cr | ₹244 Cr |
| EPS | ₹19.50 | ₹19.14 | ₹17.55 | ₹18.32 | ₹18.97 | ₹18.55 | ₹14.83 | ₹14.42 |
| Peers & Returns | 1W | 1M | 1Y |
| TORRENT PHARMACEUTICALS | 0.2% | 1.5% | 7.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -0.3% | 47.1% |
| DIVIS LABORATORIES | 1.7% | 7.3% | 53.8% |
| DR REDDYS LABORATORIES | -1.9% | 4.5% | -9% |
| CIPLA | 1.5% | 5.5% | 19.6% |
| GLAND PHARMA | -1.6% | 2.6% | NA |
| PIRAMAL ENTERPRISES | 5.6% | 6.6% | 95.6% |
| CADILA HEALTHCARE | 1.6% | 3.3% | 37.2% |
| ALKEM LABORATORIES | 5.7% | 4.8% | 38.4% |
| Revenues | |
|---|---|
| Q-o-Q | 10.17 % |
| Y-o-Y | 3.79 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2021 | ₹2,134 Cr | 10.17 | |
| Mar2021 | ₹1,937 Cr | -2.91 | |
| Dec2020 | ₹1,995 Cr | -1.09 | |
| Sep2020 | ₹2,017 Cr | -1.90 | |
| Jun2020 | ₹2,056 Cr | 5.65 | |
| Mar2020 | ₹1,946 Cr | -1.02 | |
| Dec2019 | ₹1,966 Cr | -1.95 | |
| Sep2019 | ₹2,005 Cr | - | |
| Operating Profit | |
|---|---|
| Q-o-Q | 16.32 % |
| Y-o-Y | 2.42 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2021 | ₹677 Cr | 16.32 | |
| Mar2021 | ₹582 Cr | -4.12 | |
| Dec2020 | ₹607 Cr | -4.41 | |
| Sep2020 | ₹635 Cr | -3.93 | |
| Jun2020 | ₹661 Cr | 20.62 | |
| Mar2020 | ₹548 Cr | 1.48 | |
| Dec2019 | ₹540 Cr | -0.18 | |
| Sep2019 | ₹541 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 5.56 % |
| Y-o-Y | -1.34 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2021 | 31.72% | 5.56 | |
| Mar2021 | 30.05% | -1.25 | |
| Dec2020 | 30.43% | -3.34 | |
| Sep2020 | 31.48% | -2.08 | |
| Jun2020 | 32.15% | 14.17 | |
| Mar2020 | 28.16% | 2.51 | |
| Dec2019 | 27.47% | 1.82 | |
| Sep2019 | 26.98% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 1.85 % |
| Y-o-Y | 2.80 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2021 | ₹330 Cr | 1.85 | |
| Mar2021 | ₹324 Cr | 9.09 | |
| Dec2020 | ₹297 Cr | -4.19 | |
| Sep2020 | ₹310 Cr | -3.43 | |
| Jun2020 | ₹321 Cr | 2.23 | |
| Mar2020 | ₹314 Cr | 25.10 | |
| Dec2019 | ₹251 Cr | 2.87 | |
| Sep2019 | ₹244 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -7.59 % |
| Y-o-Y | -0.96 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2021 | 15.46 % | -7.59 | |
| Mar2021 | 16.73 % | 12.36 | |
| Dec2020 | 14.89 % | -3.12 | |
| Sep2020 | 15.37 % | -1.54 | |
| Jun2020 | 15.61 % | -3.28 | |
| Mar2020 | 16.14 % | 26.39 | |
| Dec2019 | 12.77 % | 4.93 | |
| Sep2019 | 12.17 % | - | |
| EPS | |
|---|---|
| Q-o-Q | 1.88 % |
| Y-o-Y | 2.79 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2021 | ₹19.5 | 1.88 | |
| Mar2021 | ₹19.14 | 9.06 | |
| Dec2020 | ₹17.55 | -4.20 | |
| Sep2020 | ₹18.32 | -3.43 | |
| Jun2020 | ₹18.97 | 2.26 | |
| Mar2020 | ₹18.55 | 25.08 | |
| Dec2019 | ₹14.83 | 2.84 | |
| Sep2019 | ₹14.42 | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MOMENTUM | 2.8% | 7.2% | 41.8% |
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 100 | 2.5% | 7.4% | 55.5% |
| S&P BSE CARBONEX | 2.5% | 7.2% | 54.9% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE MID CAP | 2.4% | 9.8% | 69.4% |
| S&P BSE MIDSMALLCAP | 2.2% | 8.8% | 76.8% |
| S&P BSE SENSEX NEXT 50 | 2.1% | 8.9% | 59.4% |
| S&P BSE MIDCAP SELECT INDEX | 1.2% | 7.7% | 63.3% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY ALPHA LOW-VOLATILTY 30 | 2.1% | 8.2% | 47.8% |
| NIFTY NEXT 50 | 1.7% | 8.3% | 57.7% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure